When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Reactive airway disease - Wikipedia

   en.wikipedia.org/wiki/Reactive_airway_disease

   Reactive airways dysfunction syndrome was first identified by Stuart M. Brooks and colleagues in 1985 as an asthma-like syndrome developing after a single exposure to high levels of an irritating vapor, fume, or smoke. [1][5] It can manifest in adults with exposure to high levels of chlorine, ammonia, acetic acid, or sulphur dioxide, creating ...

3. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/lifestyle/youre-living-asthma-heres...

   Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

4. Asthma - Wikipedia

   en.wikipedia.org/wiki/Asthma

   Asthma is a long-term inflammatory disease of the airways of the lungs. [4] It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. [9][10] Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. [3]

5. Everything You Need to Know About Asthma, from Symptoms to ...

   www.aol.com/everything-know-asthma-symptoms...

   If you're living with asthma or know someone who is, read this. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us ...

6. Anti-asthmatic agents - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agents

   Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...

7. First Advanced Oral Treatment For Asthma - Sanofi's ... - AOL

   www.aol.com/first-advanced-oral-treatment-asthma...

   Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg ...